Design, construction, and implementation of an online platform for patients with type 1 diabetes: EncoDiab
Cañas Ortiz, Francesca
Nóvoa, Francisco Javier
Wägner, Ana María
MetadataShow full item record
Purpose: The purpose of this study was to develop, build, and implement a virtual platform equipped with practical tools, relevant contents, and communication rooms, with the aim of facilitating patients’ self-management of type 1 diabetes mellitus (T1DM). Materials and methods: The design of the platform was based on the suggestions of T1DM patients who were being managed at two reference hospitals. Patients’ needs and preferences were identified in group discussion sessions. Before having access to the platform, patients underwent a baseline assessment, which included physical examination and the administration of validated questionnaires for evaluation of clinical background, quality of life, treatment satisfaction, and well-being. Results: A total of 33 patients were included in the study; 54.5% of them were men, their median age was 34 (18–50) years, the median duration of diabetes was 15 (1–38) years, and the median A1C was 7.4% (6%–12.6%). Based on their suggestions and requests, the online platform EncoDiab was built and organized into four domains: a personal domain, two domains shared by the patients and the staff of each of the two participating hospitals, and one domain that was accessible to all participants. The platform included practical tools (a body mass index calculator, a carbohydrate counting tool, and an insulin-dose calculator), a library with relevant information (documents on prevention and treatment of acute complications, nutrition, exercise, etc), and a chat room. Conclusion: Although the study is still ongoing, our current results demonstrate the feasibility of building and implementing an online platform for helping T1DM patients in the self-management of their disease in the public health setting.
Is part ofPatient Preference and Adherence, 2015, vol. 9, p. 767–775
European research projects
The following license files are associated with this item:
Except where otherwise noted, this item's license is described as cc-by-nc (c) Alvarado-Martel et al., 2015
Showing items related by title, author, creator and subject.
Increased Burden of Cerebral Small Vessel Disease in Patients With Type 2 Diabetes and Retinopathy Sanahuja Montesinos, Jordi; Alonso, Núria; Diez, Javier; Ortega, Emilio; Rubinat, Esther; Traveset Maeso, Alicia; Alcubierre Calvo, Núria; Betriu i Bars, M. Àngels; Castelblanco Echavarría, Esmeralda; Hernández García, Marta; Purroy Garcia, Francisco; Arcidiacono, Maria V.; Jurjo Campo, Carmen; Fernández i Giráldez, Elvira; Puig-Domingo, Manuel; Groop, Per-Henrik; Mauricio Puente, Dídac (American Diabetes Association, 2016-06-08)OBJECTIVE We sought to examine the presence and severity of brain small vessel disease (SVD) in patients with type 2 diabetes and diabetic retinopathy (DR) compared with those without DR. RESEARCH DESIGN AND METHODS We ...
A prospective cross-sectional study on quality of life and treatment satisfaction in type 2 diabetic patients with retinopathy without other major late diabetic complications Alcubierre Calvo, Núria; Rubinat, Esther; Traveset Maeso, Alicia; Martínez Alonso, Montserrat; Hernandez, Marta; Jurjo Campo, Carmen; Mauricio Puente, Dídac (BioMed Central, 2014)Background: To assess quality of life and treatment satisfaction in patients with type 2 diabetes mellitus with diabetic retinopathy (DR) using validated instruments, with comparison to patients without DR. Methods: A ...
Poorer Quality of Life and Treatment Satisfaction is Associated with Diabetic Retinopathy in Patients with Type 1 Diabetes without Other Advanced Late Complications Granado Casas, Minerva; Castelblanco Echavarría, Esmeralda; Ramírez-Morros, Anna; Martín, Mariona; Alcubierre Calvo, Núria; Martínez Alonso, Montserrat; Valldeperas, Xavier; Traveset Maeso, Alicia; Rubinat, Esther; Lucas-Martin, Ana; Hernández, Marta; Alonso, Núria; Mauricio Puente, Dídac (MDPI, 2019-03-18)Diabetic retinopathy (DR) may potentially cause vision loss and affect the patient's quality of life (QoL) and treatment satisfaction (TS). Using specific tools, we aimed to assess the impact of DR and clinical factors on ...